Overexpression of miR‐181a‐5p inhibits retinal neovascularization through endocan and the ERK1/2 signaling pathway
Author:
Affiliation:
1. Department of Ophthalmology Zhongshan Hospital of Fudan University Shanghai China
2. Department of Ophthalmology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29733
Reference39 articles.
1. The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor
2. RNA Interference: Biology, Mechanism, and Applications
3. A framework for understanding the roles of miRNAs in animal development
4. Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity
5. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting MicroRNA in myopia: Current insights;Experimental Eye Research;2024-06
2. MiR-181a-5p may regulate cell proliferation and autophagy in myopia and the associated retinopathy;Experimental Eye Research;2024-04
3. High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p;Science China Life Sciences;2023-10-25
4. MicroRNA-124-3p Attenuated Retinal Neovascularization in Oxygen-Induced Retinopathy Mice by Inhibiting the Dysfunction of Retinal Neuroglial Cells through STAT3 Pathway;International Journal of Molecular Sciences;2023-07-21
5. Systemic Cytokines in Retinopathy of Prematurity;Journal of Personalized Medicine;2023-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3